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Abstract
BACKGROUND: As a cornerstone of quality management in the laboratory,
External Quality Assessment (EQA) schemes are used to assess laboratory and
analytical method performance. The characteristic function is used to describe
the relation between the target concentration and the EQA standard deviation,
which is an essential part of the evaluation process. The characteristic function is
also used to compare the variability of different analytical methods. METHODS:
We fitted the characteristic function to data from the Belgian External Quality
Assessment program for serum ethanol. Data included results from headspace
gas chromatography and the enzymatic methods of Abbott, Roche, Siemens,
and Ortho-Clinical Diagnostics. We estimated the characteristic function with
weighted nonlinear regression. By introducing dummy variables, we rewrote the
original formula of the characteristic function to assess statistical inference for
comparing the variability of the different analytical methods. R...
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BACKGROUND: As a cornerstone of quality management
in the laboratory, External Quality Assessment (EQA)
schemes are used to assess laboratory and analytical
method performance. The characteristic function is used
to describe the relation between the target concentration
and the EQA standard deviation, which is an essential
part of the evaluation process. The characteristic function
is also used to compare the variability of different analyt-
ical methods.
METHODS: We fitted the characteristic function to data
from the Belgian External Quality Assessment program
for serum ethanol. Data included results from headspace
gas chromatography and the enzymatic methods of Ab-
bott, Roche, Siemens, and Ortho-Clinical Diagnostics.
We estimated the characteristic function with weighted
nonlinear regression. By introducing dummy variables,
we rewrote the original formula of the characteristic func-
tion to assess statistical inference for comparing the vari-
ability of the different analytical methods.
RESULTS: The characteristic function fitted the data pre-
cisely. Comparison between methods showed that there
was little difference between the estimated variability for
low concentrations, and that the increase in SD with
increasing target concentration was slower for Abbott
and Roche than for the other methods.
CONCLUSIONS: The characteristic function can success-
fully be introduced in clinical schemes, although its ap-
plicability to fit the data should always be assessed. Be-
cause of its easy parameterization, it can be used to assess
differences in performance between analytical methods
and to assess laboratory performance. The characteristic
function also offers an alternative framework for coeffi-
cients of variation to describe variability of analytical
methods.
© 2015 American Association for Clinical Chemistry
A correct estimation of the variability in External Quality
Assessment (EQA)13 schemes, an important parameter
used for follow-up of laboratories and analytical method-
ologies, has received wide interest in the past (1–3 ). It is
not only used to evaluate different laboratories or differ-
ent assays, e.g., by means of z-scores, but it may also
reveal information about the state of the art of the ana-
lytical methods.
To evaluate laboratories by means of z-scores, EQA
organizers have ample choice ofmethods to obtain a stan-
dard deviation. They can calculate the SD directly from
the reported results; they may also obtain SDs from ex-
ternal sources, such as legislative documents, published
literature, or historical data (4 ). In particular, when not
enough data are available, deriving SDs from external
sources becomes interesting.
To evaluate analytical methods, EQA organizers
limit themselves to reporting the variability of several
methods for a particular target concentration andmatrix.
Various studies have underlined the advantage of com-
bining results of different EQA rounds or samples (5–8 ).
Moreover, methods have been published to combine data
from different centers or samples of the same target con-
centration (9 ). However, to the best of our knowledge,
combining data from samples of different target concen-
trations to obtain a reliable estimate of the SD has not yet
been done in the domain of EQA for clinical laboratories.
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Recently, Thompson proposed a formula to describe
the relation between the concentration of an analyte and
the SD found in EQA programs (1 ). In basic form, the
formula is given by Eq. (1):
SD 2  2 c2 (1)
where SD is the standard deviation of the EQA results,
c is the concentration of the analyte; and  and  are
coefficients that have to be estimated via a nonlinear re-
gression model.
By dividing both sides of Eq. (1) by the concentra-
tion, it can be rewritten (10 ) as follows:
CV 2c2  2 (2)
where CV is the coefficient of variation. The formula is
also called the characteristic function (1 ), since it charac-
terizes the performance of a particular system for a par-
ticular sample and measurand. The formula has been
used in method validation (11, 12 ), total error estima-
tion (13 ), and EQA schemes for analytical methods ap-
plied in the food industry and the environmental sector
(10, 14, 15 ). So far, only 1 application in the clinical
laboratory has been described (16 ).
In EQA settings, the formula can be considered
an alternative to the Horwitz function (3 ) with a wider
applicability (1 ).
The parameters  and  have a different meaning in
describing the relation between concentration and the
estimate of variability. The parameter  principally de-
termines the estimate of variability at low concentrations
and could even be used to describe the limit of quantifi-
cation (11 ). The parameter  affects the estimate of vari-
ability at higher concentrations and approaches the CV
when  is low or the concentration is high. The ratio /
determines the shape of the curve. The curve tends to a
straight line when the ratio is small and a curved convex
line when it is large.
Our aim here was to assess the feasibility of applying
the characteristic function to EQA data and compare the
different methods used in an EQA in the clinical setting.
Serum ethanol, a parameter measured with totally differ-
ent methods and relatively high precision, was used for
this purpose.
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Fig. 1. Residual dot plot for the curves of the characteristic function ﬁt for the Qn estimator for each method.
Lines are the LOWESS regression obtained for each method. Flat LOWESS regression lines indicate perfect ﬁt of the characteristic function;
curved LOWESS regression lines indicate lack of ability of the characteristic function to model the data. A graph containing all the LOWESS
regression lines together on 1 plot can be found in online Supplemental Fig. 1.
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Materials and Methods
DATA
We used data from the Belgian EQA program for serum
ethanol testing. In this program, the EQA organizers
send 5–6 ethanol-spiked fresh serum samples twice a
year. The participants are asked to treat the samples as
routine samples and return the analysis results within 2
weeks.
The median was used as a consensus value, a robust
SD was calculated by the Qn estimator (17, 18 ), and the
corresponding CV was obtained by dividing the esti-
mated Qn by the consensus value.
Ethanol data included in the study were reported
from 2010 to 2014. Overall, 50 samples were included in
the study. Samples that contained ethanol concentrations
below or equal to the limit of quantification (0.1 g/L)
were discarded. Only SDs and CVs were evaluated for
methods that were used for at least 15 different samples.
SDs and CVs on the basis of 10 reported data points
were not considered. Five methods were included in the
study: headspace gas chromatography and the various
enzymatic methods of Abbott-Aeorset (Abbott Diagnos-
tics), Dade (Dade Behring, Siemens), Roche (Roche Di-
agnostics), and Vitros (Ortho-Clinical Diagnostics). All
kits from the same manufacturer were pooled each time
into 1 group.
CALCULATING THE CHARACTERISTIC FUNCTION
We solved Eq. (1) by means of nonlinear least squares
regression with the Newton–Raphson algorithm and
with n/ei
2 as weights (19 ), where n is the number of data
that SDs were based on, and ei is the residual value, which
is the difference between the actual and predicted value
by the modeled function of data point i. The nonlinear
regression estimates were iterated, in which estimates of
the residual values in the previous step were used to cal-
culate weights in the next step. The iteration continued
until the sum of the squared residual values was mini-
mized at a precision of 106. An example of an iteration
is provided in Supplemental Data, which accompanies
the online version of this article at http://www.
clinchem.org/content/vol61/issue7. For each estimated
regression line, we calculated a 95% CI for the estimated
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Fig. 2. Residual dot plot for the curves of the characteristic function ﬁt for the CV for each method.
Lines are the LOWESS regression obtained for each method. Flat LOWESS regression lines indicate perfect ﬁt of the characteristic function;
curved LOWESS regression lines indicate lack of ability of the characteristic function to model the data. A graph containing all the LOWESS
regression lines together on 1 plot can be found in online Supplemental Fig. 2.
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line on the basis of the standard error of each predicted
value.
For each curve, residual values were plotted against
the target concentrations and visually inspected to check
the goodness of fit of the curve by means of a residual dot
plot. A nonparametric regression line on the basis of the
locally weighted scatterplot smoothing (LOWESS) (20 )
line was drawn to indicate the direction of the points
cloud. A line that followed a curvature up or down indi-
cated a lack of ability of the characteristic function to
model the data. A line that was flat with some potential
peaks up or down pointed to the ability of the character-
istic function to model the data.
COMPARISON BETWEEN METHODS
We compared methods by means of extra variables that
can be used to distinguish between methods (so-called
dummy variables). They allow 1 model to be fitted to
data obtained for 2 different methods and allow an indi-
vidual estimation of the parameter estimates for each
method individually. Depending on the method, the ex-
tra variables have values of 0 or 1. Eq. (1) was transformed
as follows:
SD 12  2 X  12  2 Xc2. (3)
The variable X was set at 0 for values from method 1 and
at 1 for values frommethod 2. An example is given in the
online Supplemental Data.
Equation (3) then becomes SD  12  12c2 for
method 1 and SD  32  32c2 for method 2,
where 3
2  1
2  2 and 3
2  1
2  2.
The values of2 and2 inform about the differences
between the methods, and their P values denote whether
differences are significant.
We calculated P values for 2 and 2 for each com-
parison between methods and corrected them for simul-
taneous hypothesis testing according to Tukey–Kramer.
Dummy variables were used as well to compare the CVs
of the methods.
Results
The residual dot plot for the Qn estimator for the 5
analytical methods for ethanol determination is shown in
Fig. 1 and for the CV in Fig. 2. The LOWESS-smoothed
lines showed a maximum deviation of 0.01 g/L, which
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Fig.3. Curvesof the characteristic function for theQnestimator for 5different analyticalmethods for serumethanol determination.
The graph labeled “All” shows the individual curves of eachmethod together on 1 plot. A graph containing all the curves together on 1 plot can
be found in online Supplemental Fig. 3.
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was the rounding error of the reported results. This
means that a possible lack of ability of the characteristic
function to model the data was of a magnitude that was
equal to or smaller than the rounding error of the re-
ported results.
The curves of the characteristic function for model-
ing the Qn are depicted in Fig. 3 and for the CV in Fig.
4. The details of the values of  and , together with a
detail of the comparison between methods, are given in
Table 1 for Qn and Table 2 for CV.
For Qn, the methods could be divided in 2 groups for
the parameter . The first group consisted of methods with
a relatively slowly increasing SD with increasing ethanol
concentration such asAbbott andRoche.The second group
(consisting of headspace chromatography, Siemens, and
Vitros) had a SD that increased relatively rapidly with in-
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Fig. 4. Curves of the characteristic function for the CV for 5 different analytical methods for serum ethanol determination.
Graph labeled “All” shows the individual curves of eachmethod together on 1 plot. A graph containing all the curves together on 1 plot can be
found in online Supplemental Fig. 4.
Table 1. Results from Eq. (1) (,) for modeling the relation between the concentration and the SDs for each method
individually, together with a detail of the comparison between methods.a
Laboratory method
Average reported
results, n
Samples taken
into account, n  CI  CI
Abbott 49 13 0.011b,c 0.0108–0.0113 0.0236b 0.0232–0.024
Roche 45 96 0.0177c 0.0169–0.0185 0.0288b 0.0282–0.0295
Siemens 47 11 0.0206c 0.0204–0.0208 0.0385c 0.0383–0.0387
Headspace chromatography 48 16 0.0127b,c 0.0126–0.0129 0.0406c 0.0406–0.0407
Vitros 47 25 0.0064b 0.0046–0.0078 0.0423c 0.0411–0.0435
a Groups with the same letter next to the parameter estimate do not differ signiﬁcantly for  or .
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creasing ethanol concentration. For the parameter , no
clear distinction was observed between the groups. The pa-
rameter was highest for the Rochemethod, although signif-
icantly different only from Vitros and Abbott.
When the information of  and  was combined
and visually represented (Fig. 3), it was clear that the
Abbott method had overall the lowest variability. In ad-
dition, the relation between SD and ethanol concentra-
tion was quite particular for the Vitrosmethod. Although
it was significantly different only from Roche, it had the
second-lowest intercept of all methods, and its slope was
the highest of all, although significantly higher than only
the slopes of Roche and Abbott. The combination of a
low  and a high  resulted in its curve going from the
second-lowest variability at low concentration to the
highest variability at high concentration.
The results for CV are shown in Table 2 and Figs.
2 and 4. The parameter , which determines the be-
havior of the line for the lower concentrations, was
lowest for Abbott and Vitros and highest for Roche
and Siemens. The parameter , which determines
rather the position of the approximately horizontal
part of the characteristic curve for the higher concen-
trations, was highest for Vitros. It was significantly
higher than the  of Abbott, Roche, and Siemens.
Headspace chromatography had an intermediate
value.
Discussion
This study demonstrates that the characteristic function,
introduced earlier in the EQAs for soil and food chemistry,
can be successfully applied to clinical EQAs. It should be
noted, however, that someprecautionsmust be takenbefore
applying the characteristic function. First of all, its applica-
bility always depends on its ability to describe the relation
between theEQA standard deviation and the target concen-
tration.Theperformanceof the characteristic functionmust
always be visually inspected with a residual plot. A nonpara-
metric regression line may be used to indicate the direction
of the point cloud that consists of the residual values: the
flatter the nonparametric regression line is, the better the
characteristic function fits the data. One may consider ac-
cepting the goodness of fit if the difference between the
highest and lowest point of the nonparametric regression
line is less than 2 times the rounding error of the reported
data, since in this case the deviation caused by a lack of fit is
smaller than or equal to the error induced by rounding.
Second, it has been suggested that only samples from the
sameorigin ormatrix canbeused to establish a characteristic
function (14).
The characteristic function’s parameters are rela-
tively easy to parameterize, and they deliver ample infor-
mation about the reproducibility of analytical methods
for any concentration in the investigated range, even for
concentrations that have not been investigated before.
When historical data are available, the estimated SDmay
be used in several aspects of the EQA process. For homo-
geneity testing, the intervial variability should be com-
pared with the SD that will be used to evaluate labora-
tories. If laboratories are evaluated on the basis of the
SD of the reported results, the EQA organizer faces the
problem of evaluating sample homogeneity with an
unknown SD. The estimated SD of the characteristic
function may act as a helpful estimate of the SD to be
expected from the future reported EQA results. Sub-
sequently, the estimated SD may be used to assess
laboratories’ performance on the basis of z-scores and
may be preferred when the SD of the reported results is
not reliable, for example, when there are not enough
data available (21 ) or when results were reported near
the limit of quantification.
Koch andMagnusson (10) already mentioned how to
compare methods with the characteristic function. It may
also be interesting to assess the statistical significance of the
differences that are found, for example, to find the method
that has the significantly lowest variability. Here, a small
extension to the characteristic function helped to confirm
significant differences between the examined methods for
the low concentrations. For example, for increasing target
Table 2. Results from Eq. (2) (,) for modeling the relation between the CV and the concentration for each method
individually, together with a detail of the comparison between methods.a
Laboratory method
Average reported
results, n
Samples taken
into account, n  CI  CI
Abbott 49 13 0.7831b 0.571–0.949 2.173b,c 1.631–2.603
Roche 45 96 1.7352d 1.539–1.912 2.5472b,c 1.986–3.005
Siemens 47 11 1.6637c,d 1.328–1.942 3.265b,c 2.062–4.131
Headspace chromatography 48 16 1.2736c 1.089–1.434 3.3511c,d 2.795–3.828
Vitros 47 25 0.5876b 0.247–0.794 3.7776d 3.22–4.263
a Groups with the same letter next to the parameter estimate do not differ signiﬁcantly for  or .
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concentrations up to 2.5 g/L, the Roche and Abbott meth-
ods exhibited the smallest increase of variability.
Finally, a note should bemade about the use of theCV
to report data. In fact, Eq. (2) shows that the CV is equal to
 for amodelwhere is forced tobe zero. It shouldbenoted
that, at least for serumethanol testing, theparameter is not
equal to zero: none of the confidence intervals in Table 2
contains zero. In these cases, and as can be seen in Fig. 4,
constant CVs are a very rough approach to the real behavior
of the variability and should not be considered independent
of the concentration except when the concentration is large
enough. Of course, it would be better to interpret  and 
rather than a single parameter that is not constant over the
whole concentration range.
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